Ritodrine

Ritodrine is a phenethylamine derivative with tocolytic activity. Ritodrine binds to and activates beta-2 adrenergic receptors of myometrial cells in the uterus, which decreases the intensity and frequency of uterine contractions. Specifically, ritodrine probably activates adenyl cyclase, thereby increasing production of cyclic adenosine monophosphate (cAMP), which in turn enhances the efflux of calcium from vascular smooth muscle cells. A lack of intracellular calcium prevents uterine myometrial contractions. Additionally, this agent may directly inactivate myosin light chain kinase, a critical enzyme necessary for the initiation of muscle contractions. It is grouped under the following drug class(es): Beta-2 agonists. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include ritodrinum, DU-21220 and DTXSID7048534. Its PubChem CID is 33572.

CAS No 26652-09-5
Molecular Formula C17H21NO3
Molecular Weight 287.35 g/mol
Synonyms 4-[2-[[(1R,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]amino]ethyl]phenol

Frequently Asked Questions